Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Nimesulide is a nonsteroidal anti-inflammatory drug (NSAID) with pain medication and fever reducing properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis, and primary dysmenorrhoea in adolescents and adults above 12 years old.
History, Community, Culture & Applications
Explore the main themes, entities and connections around Nimesulide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug liver use pain risk effects 15 12 days problems available ema medicines may children side profile also following action
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Nimesulide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Nimesulide | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Nimesulide | ATC code | M01AX17 (WHO) M02AA26 (WHO) | 1.00 | infobox |
| Nimesulide | CAS Number | 51803-78-2 Y | 1.00 | infobox |
| Nimesulide | ChEBI | CHEBI:44445 N | 1.00 | infobox |
| Nimesulide | ChEMBL | ChEMBL56367 Y | 1.00 | infobox |
| Nimesulide | ChemSpider | 4339 Y | 1.00 | infobox |
| Nimesulide | CompTox Dashboard (EPA) | DTXSID3037250 | 1.00 | infobox |
| Nimesulide | DrugBank | DB04743 N | 1.00 | infobox |
| Nimesulide | ECHA InfoCard | 100.052.194 | 1.00 | infobox |
| Nimesulide | Elimination half-life | 1.8–4.7h | 1.00 | infobox |
| Nimesulide | Excretion | Renal (50%), fecal (29%) | 1.00 | infobox |
| Nimesulide | Formula | C13H12N2O5S | 1.00 | infobox |
| Nimesulide | IUPHAR/BPS | 7401 | 1.00 | infobox |
| Nimesulide | KEGG | D01049 Y | 1.00 | infobox |
| Nimesulide | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Nimesulide | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Nimesulide | Metabolism | Hepatic (via CYP2C9) | 1.00 | infobox |
| Nimesulide | Molar mass | 308.31 g·mol−1 | 1.00 | infobox |
| Nimesulide | Protein binding | >97.5% | 1.00 | infobox |
| Nimesulide | PubChem CID | 4495 | 1.00 | infobox |
| Nimesulide | Routes of administration | By mouth, rectal, topical | 1.00 | infobox |
| Nimesulide | UNII | V4TKW1454M | 1.00 | infobox |
| Nimesulide | is a | nonsteroidal anti-inflammatory drug | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.